Veru Inc. (VERU) Announces Acquisition of Novel Proprietary Formulation for Overactive Bladder
Tweet Send to a Friend
Veru Inc. (NASDAQ: VERU) today announced that it has acquired world-wide rights to a novel, proprietary oral granule formulation for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
